Among 247 study participants, the vaccine booster candidate proved effective against variants of concern 15 days after immunization.
The results are pending publication in a peer-reviewed journal, and the company plans to pitch the data to regulators in a few weeks.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.